OEIS 2018: Stop by Biomedix at Booth 202 to find out more about PADnet
The newest device for front-line PAD diagnostics
PADnet 4.0, performs tests faster, is more secure, and is more portable than ever. PADnet enables medical staff familiar with using a blood pressure cuff to generate valuable diagnostic data, including ABIs, TBIs, and PVRs – even detecting venous reflux disease.
Detecting a deadly chronic condition
Stop by our booth at OEIS to learn more about our new offerings, including PADnet Connect, and how you can partner with Biomedix to save limbs and save lives.
Biomedix Booth #202
Outpatient Endovascular and Interventional Society 2018 Annual Meeting
April 20th-21st, 2018
Fairmont Scottsdale Princess
7575 E Princess Dr
Scottsdale, AZ 85255
Archives
- September 2024 (2)
- January 2024 (1)
- October 2023 (2)
- September 2023 (2)
- August 2023 (1)
- May 2023 (1)
- March 2023 (3)
- February 2023 (7)
- January 2023 (1)
- November 2022 (2)
- October 2022 (1)
- July 2022 (1)
- May 2022 (2)
- March 2022 (2)
- February 2022 (4)
- January 2022 (14)
- December 2021 (1)
- November 2021 (3)
- September 2021 (5)
- August 2021 (1)
- July 2021 (2)
- June 2021 (1)
- May 2021 (1)
- April 2021 (1)
- March 2021 (1)
- February 2021 (4)
- January 2021 (1)
- December 2020 (2)
- November 2020 (5)
- October 2020 (7)
- September 2020 (5)
- August 2020 (3)
- July 2020 (3)
- June 2020 (7)
- May 2020 (1)
- April 2020 (2)
- March 2020 (1)
- December 2019 (1)
- November 2019 (1)
- October 2019 (2)
- September 2019 (1)
- February 2019 (1)
- January 2019 (1)
- November 2018 (2)
- September 2018 (2)
- August 2018 (4)
- July 2018 (6)
- June 2018 (4)
- May 2018 (10)
- April 2018 (6)
Recent Posts
- Biomedix Sponsors Advanced Diagnostic Technology to Enhance Education at Western University of Health Sciences College of Podiatric Medicine September 30, 2024
- Biomedix Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance September 3, 2024
- New patient-facing PADnet video available January 12, 2024
